Global Legionella Testing Market Size (2024 - 2029)

Legionella Testing Market Analysis

The Global Legionella Testing Market size is estimated at USD 349.01 million in 2024, and is expected to reach USD 516.86 million by 2029, growing at a CAGR of 8.17% during the forecast period (2024-2029).

The emerging COVID-19 pandemic affecting the respiratory system, increased awareness about sanitization, and increased attention on the prevention of infectious diseases are all significantly influencing the market during COVID-19. According to the study published Pneumonia in January 2021, titled "Legionnaires' disease in the time of COVID-19" stated that because of similarities in initial clinical presentation, physicians may be tempted to screen community-acquired pneumonia cases for COVID-19 before identifying the need to test for Legionnaires' disease. Thus, an increase in pneumonia testing may positively influence the market during the COVID-10 pandemic.

The market is experiencing considerable growth, due to factors, like the rising incidence of pneumonia and legionella-related illnesses and increasing demand for rapid advanced diagnostic techniques and technological advancements in the field of bacterial testing. Legionella pneumonia is a relatively uncommon cause of community-acquired pneumonia. For instance, according to a study published in August 2021 titled 'Community-Acquired Pneumonia,' the estimated worldwide incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with geography, season, and population factors all playing a role. The annual incidence in the United States is 24.8 cases per 10,000 adults, with rates increasing with age. Because of the high occurrence, early proper preventive measures are required, which is predicted to fuel the growth of the legionella testing market.

As per the report published in May 2022 by European Centers for Disease Prevention and Control, legionnaires' disease is still a rare and occasional respiratory infection, with an overall reported rate of 1.9 cases per 100,000 people in Europe in 2020. France, Germany, Italy, and Spain accounted for 72% of all registered cases. Legionnaires disease is not contagious, but the disease can be contracted by contaminated water droplets and mist. Thus, an increase in the incidence of legionnaire disease is expected to propel the growth of the market.

Thus, all aforementioned factors are expected to boost market growth over the forecast period. However, issues in sensitivity of diagnostic tests may restrain the market growth over the forecast period.

Legionella Testing Industry Segmentation

As per the scope of the report, legionella testing is a method to check the presence of Legionella bacteria in the sample. It is a pathogenic organism that causes Legionellosis, a respiratory disorder (a form of pneumonia). Legionellosis requires intensive care and hospitalization. Hence, it is considered one of the public health concerns. The Legionella Testing Market is segmented By Test Type (Culture Method, Urinary Antigen Test (UAT), Direct Fluorescent Antibody (DFA) Test, Polymerase Chain Reaction (PCR), Other Test Types), Application (Clinical Testing Method and Environmental Testing Method), By End User (Hospital and Clinics, Diagnostics Laboratory), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.